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Epidermal thymocyte acti va ting facto r (ET AF) is sponta-
neously released into the media by PAM 212 and A 431 
cell lines and cultured normal human keratinocytes. ET AF 
fro m all 3 cell types can substitute fo r interleukin 1 (IL-l) 
in the augmentation of proliferation of a helper T-cell clone 
(DIO.G4.1) induced by mitogen. H ydrocortisone (He) 
substantially reduces the release of ET AF by th ese kerat-
inocytes and, fu rther, appears to induce the release of an 
I nterleukin 1 (IL-1) , a poly peptide released by cells of the m onocyte and m acrophage lineage, mediates a wide variety of inflammatory responses [1 ,2]. Keratinocytes produ ce a cytokine w hich is biochemica ll y and fun ctionall y similar to IL-1 and is termed epidermal cell-derived thy m ocyte acti-
va ting fac to r o r ETAF [3,4]. Like IL-1 , ETAF is a lymphocy te 
activa tin g fac tor (LAF), a pyrogen , an inducer of acute phase 
reactant synthesis, a mitogen fo r fi bro blas ts, and is chem otactic 
fo r n'eutrophils and T cells [1-6]. T he discovery th at an IL-1-like 
m o lecule is produced by keratinocytes, together w ith the evidence 
th at IL- l has an impo rtant role in inflammation , has led to spec-
ulation concerning the role o f ETAF in cutaneous inflammatio n. 
We exa m ined the regulation of ETAF release from cultured 
epiderm al cells, including PAM 212, a spo ntaneously transfo rmed 
m ouse keratinocyte cell line [7], and A 431, a cell line derived 
fro m a human vul var carcino m a [8], bo th o f w hich had alread y 
been shown to release ET AF into the media. Long-term cultures 
of neo natal hum an fo reskin keratinocytes (HFEC) were also ex-
amined . In these studies, w e exa mined the LAF ac tivity of ET AF. 
T he assay most frequentl y used fo r LA F acti vity is the murine 
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Abbreviations: 
CM: conditioned medium (-ia) 
Con A: concanavalin A 
ETAF: epidermal cell-derived thymocyte activa ting fac tor 
GCS: glucocorticosteroid(s) 
HC: hydrocortisone 
HFEC: human foreskin epidermal cells (keratinocytes) 
HPLC: high-performance liquid chromatography 
lL-l : in terleukin 1 
LAF: lymphocyte activa ting factor 
WBC: white blood cell (s) 
inhibi to r of lymphocyte acti va ting facto r activity of IL-1. 
Irradiation w ith UVC causes in creased ET AF release into 
the media. H ydrocortisone abroga tes this effect. T hus HC 
reduces both constitutive and elicited release ofET AF. ET AF 
plays a maj or role in inflammation; the ability o f H C to 
block ET AF release by keratinocytes may account fo r the 
anti-inflammatory effect of glucocorticosteroids on the skin. 
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thym ocytc costimulator assay [9]. Wc have chosen a m o re sen-
siti ve assay for LAF activity in w hich a cloned T hel per lym-
phocy te, D 1 O. G4.1, is the respondcr cell [1 0]. 
In this study we dem onstrate that hydrocortisone (H C) redu ces 
ETAF release fro m cultured keratinocytes. W e propose that this 
effect o n ETAF may un derlie the an ti- infl ammatory effects of 
glucocorticosteroids (GCS) on skin . 
MATERIALS AN D M ETHODS 
Chemicals Hyd rocortisone and conca navalin A (Con A) were 
obtained fro m Sig m a C hemical Company (S t. Louis, Missouri). 
Cell Cultures PAM 212, a spontaneously transformed kerati-
nocytc line fro m B ALBlc mi ce, was prov ided by D r. Pam ela 
H awley-Nelson (N ational Cancer Insti tute) . A 431, a tetraplo id 
epidermal cell line fro m a v ul va r carcino m a, was pro vided b y 
D r. Lloyd Kin g (Vanderbilt University) . Both cell lines were 
maintained in D ulbecco's minimal essential medium (Gibco) w ith 
10% ca lf serum. Confluent cul tures were used fo r experiments. 
N eonata l hum an fo reskin was the so urce of no rmal human 
kerat inocytes (H FEC). T he cultures were ini tiated and main ta ined 
by the techniqu e o f Rhein wa ld and G reen [11 J. 
In experiments w hich m easured the effect of H C on ETA F 
pro du ction , cultures w ere grown ill the presence or absence of 
H C under serulII-free conditions. M edia collected from these cul-
tures were extensively dialyzed aga inst Cantor 's balanced salt 
solution . 
010 Assay for Interleukin1 D l 0.G4.1 (DlO), a murine helper 
T - cell clone, and 3D3, a m onoclo nal clo no type-specific antibody 
w hi ch acti va tes the T - ccll recepto r o f Dl 0, w ere provided by C. 
J aneway, Jr. (Yale Uni versity) . D 10 cells w ere maintained as 
prcv io usly described [1 0]. 
M easuremcnt o f lL- l activity utilizcs 0 10 as a responder cell 
and either Con A or the cl ono type-specifi c m o noclonal antibody 
303 as costimulus, as described by Kaye and Janew ay [1 0]. B riefl y, 
2 X 104 D lO cells, a 1:1000 dilutio n o f 3D3 hybrido m a super-
natant, or 2.5 JLg/ ml of Con A , and the experimental sample were 
cocul tured in triplicate in a fin al volume of 200 JLI in Costar 96-
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well tissue plates . Clicks medium with 5% feta l calf serum was 
used and cultures were incubated for 72 h at 37°C in a 5% COz195% 
air incubator. Six hours before harves t, Ip.C i/well of[3H]thymidine 
was added. C ultures were harvested on a MASH (Cambridge 
Technologies) and counted in a Beckman scintillation spectrom-
ete r. 
UVC Irradiation Keratinocyte cultures in serum-free media 
were irradiated w ith 0.1 J/c m2. Fresh medium was then added 
and cultures were incubated for another 24 h . Medium was then 
removed and dialyzed aga inst phosphate-buffered saline. 
RESULTS 
Previous studies in our laboratory have shown that m edia con-
ditioned by HFEC contain less than 5% of ETAF/LAF activity 
of m edia conditioned by PAM 212 and A 431 (unpublished). 
Hydrocortisone 10 - 6 is routinely included in the media of hum an 
keratinocyte cultures [11], but is not present in PAM 212 and A 
431 m edia . When HFEC were cultured in the absence of HC, 
ET AF act ivity in the medium was increased to levels equivalent 
to those found in PAM- and A 431-conditioned m edia (CM). 
GCS directly inhibit T -lymphocyte proIiferation , in part by 
inhibiting transcription of the IL-2 gene [1 2J. Since LAF activity 
is thought to depend on the synthesis oflL-2 by T cells in response 
to IL-l and mitogen 1'13], it was not surprising that undialyzed 
e M containing H C inhibited DI0 proliferation in the IL- 1 assay. 
When D10 proliferation in response to ET AF/ IL-1 and Con A 
was measured in the presence of varying amounts of HC, the 
inhibitory effect of H C was clea rly dose dependent. H C at a final 
con centration of2.5 X 10 - 6 M co mpletely inhibited proliferation 
of DlO; fin al concentrations of 2.5 X lO - M M HC or less were 
not inhibitory (data not shown) . It was determined that dialysis 
effectively removed HC in serum-free CM so that final concen-
trations of HC, as tes ted by radioimmunoassay, were less than 
2.5 X 1 O- M M. In the present study, CM was never used at g reater 
than a 25% (vol/vol) concentration in the 010 assay . Therefore, 
direct inhibition of D1 0 by H C was not o bserved when dial yzed 
serum-free media w ere tested. 
To determine whether HC inhibited ET AF release by kerat-
inocytes, HFEC and PAM 212 were grown under serum-free 
conditions in the absence of HC or in the presence of 10 - 6 and 
10 - 5 M He. Fig 1 (HFEC) and Fig 2 (PAM 212) show that 
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Figure 1. Reduction of HFEC, ETAF by He. HFEC was cultured under 
serum-free conditions for 10 days in either 10- (' M (triangles), 10- 5 M 
(squares), or no (circles) He. All CM were dia lyzed prior to incubation 
with 010. Serial di lutions ofCM were mixed with 2 x 10' 010 cells in 
Clicks medium with 5% fetal ca lf seru m to a final concentration of 25% 
by volume. 303 was used at a final concentration ofl:1000. 
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Figure 2. Reduction of PAM 212 ETAF by He. Conditions are identical 
to Fig l. No HC (circles), 10- " M HC (sqllares) , 10 - 5 M HC (trimlgles) . 
ET AF/LAF activity in media from these cell lines is significant 
when they were cultured in the absence of H C for 10 days. 
ETAF/LAF activity in CM was progressively reduced when cells 
w ere grown in the presence of 10 - (' M or 10 - 5 M HC over the 
same time period . This effect was more striking on PAM 212 
cultures; in the presence of 10 - 5 M H C, ETAF release by PAM 
212 is co mpletely blocked. Cell viability and morphology, how-
ever, were similar in all groups under all of the above conditions. 
Furthermore, total protein was not diminished in the cultures by 
10 - 5 M HC (data not shown). These experiments indicated that 
release of ET AF into the m edia was inhibited by He. 
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Figure 3. Reduction of constitutive and UV-elicited ETAF by HC in 
HFEC media. HFEC were grown in the presence (10 - ") and absence of 
HC for 72 h under serum-free conditions. At this time, some cultures 
received 0.1 Jlcmz of UVC (254 mn). Fresh media with or without 10- 6 
M HC were added to all cultures and removed 24 h later. These media 
were dia lyzed extensively before inclusion in the 010 assay. Conditions 
of the 010 assay are those outlined in Figs 1 and 2. Groups are: no HC 
(0--0); no HC. UVC (6-6); 10- 6 M HC (0-0); and 10 -(' M HC, 
UVC(e-e) . 
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UV irradiation has been shown to enhance ET AF release by 
keratinocytes [14] . We asked whether HC influenced the amount 
of ET AF released after UV irradiation . Spontaneous ET AF re lease 
from HFEC is signifi ca ntly redu ced by 10- 6 M HC (Fi g 3). Fur-
thermore, whi le cells irradiated in the absence of HC released 
signifi ca ntly more ETAF than unirradiated cells, cells irradiated 
in the presence of H C released significantly less additional ET AF. 
Thus, both constitutive and eli cited ET AF release are inhibited 
by He. 
Urine, serum, and media from certain cell cultures contain 
inhibi tors of LAF activity [15-17] . Therefore, the possibility that 
keratinocytes grow n in HC produced an inhibitor of ET AF/LAF 
act ivity was tested. M edia from cells grown in the presence of 
10- 5 M H C still inhibited ETAF activity even after dialysis, which 
reduced H C to levels not inhibitory to 010 (as determined by 
rad io immunoassay). This finding suggested the presence of a non-
dia lyzab le inhibitor. C M from all 3 cell lines contained an inhib-
itor(s) which decreased proliferation of 010 in response to ETAF 
(Fig 4(/). This inhi bit ion by both HFEC- and PAM-CM, wh ile 
sign ifi cant at a 1:4 dilution, was not seen at a 1 :36 dilution (Fig 
4(/). At this dilution, however, there was sti ll less LAF activity 
in media from cells grown in the presence of HC than in media 
from cells g rown in the absence ofHC (Fig 4&). While an inhibitor 
may account in part for the differen ce in LAF activity at 1:4 
di lutions , the differen ce in LAF activity between cells g rown in 
the presence o r absence of HC at the 1 :36 di lu tion cannot be 
att ributed to the presence of inhibitor(s) alone. CM from A 431 
cells cultured with H C contained very high levels of inhibitory 
activ ity which was significant even at a 1 :160 di lu tion. Since little 
LAF activity was demonstrable in A 431 grown with HC even 
at such dilutions, the relative contribution of inhibitor vs dimin-
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Figure 4. n, Inhibition of ETAF/LAF activity by media from keratino-
cytes grown in the presence of He. PAM 212, HFEC, and A 431 cells 
were grown in Du lbecco's minimal essential medium (10 - 5 M HC) with-
out serum for 10 days . Media were then collected and dia lyzed. Inhibition 
of LAF activity by dia lyzed media from cells grown in the presence of 
HC was tested as fo llows: serum-free CM from either PAM, HFEC, 
or A 431 cells grown in the absence of HC and containing 50 U/ml of 
LAF activity was added to 010 and Con A as previously described. In 
addition to this ET AF control, serial di lutions of dia lyzed media from 
the corresponding cells grown in the presence of 10 - 5 M HC were added 
to the cultures. b, Reduced LAF activity in media from cells grown in 
the HC reAects reduced ETAF release. Both PAM 2]2 and HFEC cells 
were grown for 10 days in the presence or absence of 10- 5 M HC. These 
media were dialyzed and tested for LAF activity at 1 :36 di lution, a dilution 
at which no inhibitory activity from PAM 212 and HFEC medium cou ld 
be demonstrated in the OW assay (see n) . These results demonstrate that 
there is significantly less LAF activity in mcdia from cel ls grown in 10- 5 
M HC independent of the effect of HC and the HC-induced inhibitor or 
the 0 10 assay . 
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Figure 5. Gd filtration HPLC analysis of media from HFEC grown 
undcr serum-free conditions in the presence or absence of HC. Media 
from HFEC grown for 10 days in 10- 5 M HC (solid circles) or in its absence 
(OpCII circles) wcre dialyzed P 01 and tested for LAF activ ity in the 010 
assay. Media from cells grown in the absence ofHC contained 36 units/ ml 
and media from cells grown in 10 - 5 M HC contained 8units/ml. A volume 
of 0.5 ml was analyzcd by HPLC using a Biosil TSK 250 column. The 
Aow rate of the mobile phase (PBS) was 1 ml /min. Twenty-four fractions 
of 0.5 ml each were collected, filtered, diluted 1:2 in tissue culture me-
dium, and tested at a 1:4 dilution in the 010 assay. Molecular weight 
standards were run separately. 
ished ETAF release to LAF activity could not be determined for 
this cell linc. 
The observation that an inhibitor was present in the media of 
cells grown in HC raised 3 possibilities : (1) HC does not affect 
ETAF release; decreased ETAF activity is due to the presence of 
an inhibi tor. (2) HC reduces ET AF release in addition to gen-
erating an inhibitor of ETAF activity. (3) By reducing ETAF 
release, HC reveals the presence of a constitutive inhibitor which 
is not influenced by altering HC concentration. In order to test 
the first 2 possibilities, medium from HFEC grown in the pres-
ence or absence oflO - 5 M HC was analyzed by gel filtration high-
performance liquid chromatography (HPLC) using a TSK-250 
column . All of the ETAF/LAF activity from cells grown in the 
absence of HC elutes in a sin gle fraction (Fig 5) between 15-20 
kO. Media from cells grown in HC contain significantly less LAF 
activity in this fraction. N one of these fractions inhibited OlO 
proliferation, thus eliminating the possibility that ET AF and the 
inhibitor coelute and suggesting that gel filtration HPLC of un-
conditioned m edia probably reduced the concentration of the in-
hibitor to below detectable levels. Preliminary evidence, from 
studics using the A 431 cell line, suggest that the inhibitor is larger 
than 50 kO (data not shown). 
O ISCUSSION 
These observations indicate that in both HFEC and PAM 212 cell 
lin cs, HC effects both diminished release of ETAF and either 
reveals or induces a factor which antagonizes its LAF properties. 
It is not known whether this inhibitory factor(s) has an effect on 
other activities of ETAF (e.g., fibroblast activation), and its rel-
evance in vivo remains to be demonstrated. 
HC is normally present at 5 x 10 - 7 M in human serum, but 
may reach more than 3 times this level with severe stress [18,19]. 
It may be physiologically significant that 10- (' M HC inhibi ts 
ET AF release by both human and murine keratinocytes. Con-
versely, cells grown in the absence of HC spontaneously release 
large amounts of ET AF into the culture medium . On the basis 
of this relationship between HC and ET AF release, it can be 
speculated that release of ET AF in the epidermis may correlate 
inversely with the concentration of HC in tissue. 
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Inflammato ry disorders of the skin are often trea ted with cor-
ticosteroids. The observation th at pharmacologic concentratio ns 
of H C (10 - 5 M) . m ore co mpletely inhibit ET AF release than ph ys-
iologic levels sugges ts a m echanism b y w hich GCS m ay modify 
ET AF-induced features of the inflam m atory response: recruit-
m e nt of neut rop hils and m ononuclea r cells from the system ic 
circ ulatio n, stimulation of fibrobl as t proliferation and prosta-
g la ndin production, and activation ofT ly mphocytes [1-6]. Since 
ET AF has been linked to the initiation and m aintenance of wou nd 
hea lin g, it ca n be speculated that the profound inhibitory effec ts 
of hi g h levels of GCS o n wound healin g m ay result in part from 
inlpaired ET AF release at the wound . 
In 1970 co rtisol was shown to redu ce th e am o unt of endogeno us 
py r ogen released from hum an white blood cells (WBC) prepa-
rations in respo nse to phagocytosis of hea t- killed staphylococci 
[20]. This o bservation m ay now be interpreted as a co rtisol-me-
diated reductio n in the release of IL-1 from m acrophages present 
in the WBC preparation. M o re recently , media conditioned by 
both murin e [21) and ra t [22) peritoneal exudate ce lls stimulated 
with lipopo lysaccharide or carageenan were shown to contain less 
LAF activity in the presence of H e. It is notable that 10 - 6 M H C 
was effective in blocking IL-l release from m acrophages in these 
studies. H o w ever, while suggestin g a relationship between cor-
ticosteroids and IL-1 release, these studies w ere perfo rmed on 
h e terogenous cell pop ul atio ns and could not conclusivel y prove 
th at the effect of cort icos teroid s o n m acropha ges was not me-
dia t ed by a no n macrophage cell type. The use ofkeratinocyte cell 
lines and long-term cultures o f hum an kera tin ocytes in this report 
indica tes that the effect of co rticos teroids o n ETAF release b y 
kera tin ocytes does not require the presence of another cell type. 
T he m echanism by which H C regul ates ETA F release cannot 
b e determined from the present study . M any stero ids exert their 
effect by regulatin g gene transcription [23,24]. It is possible that 
tra n scriptio n of the ETAF/ IL-l gene is inhibited by HC; it is also 
possible that H e regulates another gene product which influences 
the release of ETAF from the keratinocyte. T he use of cD NA 
probes fo r both murine [25] and human [26]IL-1 will determine 
w h e ther corticos teroids regulate ET AF/ IL-1 gene express io n , and 
th ese studies are currently under way in o ur labo rato ry. 
In summary , cultures of A 431, PAM 212, and HFEC all spo n-
ta neously release ETA F into the m edia. From all 3 keratinocyte 
cel l types, ETAF ca n su bstitute for IL-1 in the aug mentation of 
proliferatio n of DIO cells induced by mitogen o r by activation of 
the T-cell receptor by a monoclonal antibody. Growth of these 
keratin ocytes, in the presence of physiologi c o r pharmacologic 
concentrations of HC, results in a sig nificant redu ction of 
ET AF/LAF activity . This occurs by 2 m echanisms: redu ction of 
the release of ET AF by keratinocytes and the release of an inhib-
itor of LAF activ ity. 
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